Arnaud S Girard

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.

Eloi Gagnon, Dipender Gill, Jérôme Bourgault

|Mar 13, 2025
Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis.

Arnaud S Girard, Audrey Paulin, Hasanga D Manikpurage

|Jun 27, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targets.

Eloi Gagnon, Arnaud Girard, Jérôme Bourgault

|Jan 20, 2024
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.

Émilie Gobeil, Jérôme Bourgault, Patricia L Mitchell

|Sep 27, 2023
Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis.

Hasanga D Manikpurage, Audrey Paulin, Arnaud Girard

|Apr 20, 2023
Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression.

Arnaud Girard, Emilie Gaillard, Rishi Puri

Pageof 1

Frequent Collaborators

6 joint publications

Patrick Mathieu

6 joint publications

Benoit J Arsenault

5 joint publications

Sébastien Thériault

4 joint publications

Audrey Paulin